Risks of rare blood clot even lower with second dose of AstraZeneca, experts say

The risk of developing rare blood clots is even lower when receiving a second dose of the AstraZeneca COVID-19 vaccine, with experts reiterating that the benefits outweigh the risk in Canada's race to get inoculated.